Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry

A new NIR-based hyperspectral imaging system delivers real-time, label-free material analysis – at a fraction of the cost of conventional approaches

New chemistry-free, light-based chromatography method offers gentler – and more efficient – route to protein purification

The toughest peer review? A group of investors around a table, says Chad Mirkin, who talks commercialization lessons learned.

Green tea characterizations, isomeric PFAS analysis, and more tooth-based truths

Five pioneers explore new frontiers in the quest to protect our planet – as part of our special collection of recent environmental content

We feel the time is right for sober reflection, fresh thinking, and new solutions – “Leading Voices,” in other words

High-throughput nanoparticle analysis enhances diagnostic sensitivity

Are dark clouds on the horizon for the food and beverage industry as regulators ponder wholesale PFAS bans and consumer lawsuits multiply?

In the fourth installment of our series, our experts offer advice for navigating the regulatory pitfalls associated with nitrosamines